• BMB Reports
• /
• 제39권1호
• /
• pp.76-83
• /
• 2006

Pyridoxine-5-P oxidase catalyses the terminal step in the biosynthesis of pyridoxal-S-P, the biologically active form of vitamin $B_6$ Which acts as an essential cofactor. Here, a human brain pyridoxine-5-P oxidase gene was fused with a gene fragment encoding the HIV-1 Tat protein transduction domain (RKKRRQRRR) in a bacterial expression vector to produce a genetic in-frame Tat-pyridoxine-5-P oxidase fusion protein. Expressed and purified Tat-pyridoxine-5-P oxidase fusion protein transduced efficiently into PC12 cells in a time- and dose-dependent manner when added exogenously to culture media. Once inside the cells, the transduced Tat-pyridoxine-5-P oxidase protein showed catalytic activity and was stable for 48 h. Moreover, the formation of pyridoxal-5-P was increased by adding exogenous Tat-pyridoxine-5-P oxidase to media pre-treated with the vitamin $B_6$ precursor pyridoxine. In addition, the intracellular concentration of pyridoxal-S-P was markedly increased when Tat-pyridoxal kinase was transduced together with Tat-pyridoxine-5-P oxidase into cells. These results suggest that the transduction of Tat-pyridoxine-5-P oxidase fusion protein presents a means of regulating the level of pyridoxal-5-P and of replenishing this enzyme in various neurological disorders related to vitamin $B_6$.

• Parasites, Hosts and Diseases
• /
• 제34권2호
• /
• pp.135-142
• /
• 1996

톡소포자충(Toxoplosma gondii) 주요막단백질의 하나인 30 kDa 단백질(p30)의 항원부위를 결정하고자 p30의 아미노산 분석에 따른 친수성 부위 및 혐수성 부위에 맞게 유전자를 증폭하고 발현시켜 항원성을 검토하였다 p30의 절편으로는 p30 전체 p30의 N-말단 Signal Sequence와 C- 탈단의 혐수성 부위를 제거한 S28. S28의 N-말단 2/3부위인 Al9. S28의 C-말단 2/3부위인 Pl9. 528의 N-탈난 1/3부위인 X9 중앙 1/3부위인 Y10 및 C-말단 1/5부위인 Z9로 구성하였다. 각절편에 대한 primer에는 EcoR I의 clampsequence를 포함시켜 중합효소반응으로 증폭시켰으며 G57를 발현하는 pGEX-4T-1 vector에 삽입시킨 후 Eschericha coli(.JM105 strain)에 형질변형시키고 IgG로 각 절편이 GST와 융합단백질로 발현되도록 하였다 SDS-PAGE상에서 p30은 63 kDa. S28는 54 kDa Al9과 Pl9은 각각 45 kDa. X9은 35 kDa. Y10은 36 kDa 및 29은 35 kDa 단백질로 발현되었다. 각각의 단백질은 westemblot상에서 GSTdetectionkit와 잘 반응하여 융합단백질임을 확인하였다. 톡소포자충증 환자 혈청과 westem blot에서 p30. S28 및 Al9은 반응하여 항원성이 인정되었으나 Pl9 . X9, Y10 및 Z9는 반응하지 않았다 따라서. p30의 중간 1/3 부위의 존재하에 N-말단 1/3부위가 항원성을 나타내는 구조적 항원이거나. 첫 1/3부위와 중 간 1/3부위의 경계에 위치한 polypeptide가 항원성을 발현하는 것으로 추정되었다.

• 대한의생명과학회지
• /
• 제13권4호
• /
• pp.251-261
• /
• 2007

A myofiber of skeletal muscle is composed of myofibrils, sarcolemma (plasma membrane), and constameres, which anchor the myofibrils to the sarcolemma. Achvillin is a recently identified F-actin binding muscle protein, co-isolates with dystrophin and caveolin-3 in low-density sarcolemma of striated muscle, and colocalizes with dystrophin at costameres, the specialized adhesion sites in muscle. Archvillin also binds to nebulin and localizes at myofibrillar Z-discs, the lateral boundaries of the sarcomere in muscle. However other roles of archvillin on the dynamics of myofibrillogenesis remain to be defined. The goal of this study is, by using siRNA-mediated gene silencing technique, to investigate the effect of archvillin on the dynamics of myofibrillogenesis in cell culture of a mouse skeletal myogenic cell line (C2C12), where presumptive myoblasts withdraw from the cell cycle, fuse, undergo de novo myofibrillogenesis, and differentiate into mature myotubes. The roles of archvillin in the assembly and maintenance of myofibril and during the progression of myofibrillogenesis induced in skeletal myoblast following gene silencing in the cell culture were investigated. Fluorescence microscopy demonstrated that the distribution of archvillin was changed along the course of myofibril assembly with nebulin, vinculin and F-actin and then located at Z-lines with nebulin. Fluorescence microscopy demonstrated that knockdown of mouse archvillin expression led to an impaired assembly of new myofibrillar clusters and delayed fusion and myofibrillogenesis although the mouse archvillin siRNA did not affect those expressions of archvillin binding proteins, such as nebulin and F-actin. This result is corresponded with that of RT-PCR and western blots. When the perturbed archvillin was rescued by co-transfection with GFP or Red tagged human archvillin construct, the inhibited cell fusion and myotube formation was recovered. By using siRNA technique, archvillin was found to be involved in early stage of myofibrillogenesis. Therefore, the current data suggest the idea that archvillin plays critical roles on cell fusion and dynamic myofibril assembly.

• 한국잠사곤충학회지
• /
• 제52권2호
• /
• pp.102-109
• /
• 2014

본 연구의 목적은 누에형질전환 기술과 피브로인 재조합 단백질 발현시스템을 이용하여 황색형광실크를 개발하는 것으로서, 본 실험에서는 피브로인 H-chain의 N-말단과 C-말단을 이용하여 피브로인 재조합 단백질 발현 시스템을 제작하였고, 종결코돈이 없는 EYFP 유전자를 위의 발현 시스템에 클로닝하여 황색형광실크를 제작하였다. 누에형질전환체 선발을 위해서는 3xP3 promoter와 EGFP 유전자를 이용하여 선발하였고, 3,060개의 누에알에 microinjection 하여 F1 세대에서 8 bloods의 누에형질전환체를 선발하였다. 선발된 누에형질전환체는 초기배 단계의 눈과 신경조직, 유충과 번데기 그리고 성충의 눈에서 EGFP 형광단백질이 발현되는 것을 확인할 수 있었다. 또한 실크의 피브로인에서 EYFP 단백질이 발현되는 것을 확인하기 위해, F2세대의 누에형질전환체중에서 5령 3일 유충의 견사선을 형광현미경으로 관찰하였고, 중부 견사선에서 황색형광단백질이 발현되는 것을 확인할 수 있었다. 또한 F2 세대의 고치와 저온에서 정련한 실크에서도 황색형광단백질의 발현을 확인할 수 있었고, Western blot 분석에서도 EYFP 재조합 단백질이 피브로인 H-chain과 융합된 형태로 존재하는 것이 확인되었다. 이상의 결과에서 황색형광실크를 생산하는 누에형질전환체가 성공적으로 제작되었음을 확인할 수 있었다.

• 한국잠사곤충학회지
• /
• 제50권2호
• /
• pp.87-92
• /
• 2012

본 연구의 목적은 누에형질전환 기술을 이용하여 적색형광실크를 개발하는 것으로서, 본 실험에서는 피브로인 H-chain의 N-말단과 C-말단을 이용하여 피브로인 재조합 단백질 발현 시스템을 제작하였고, 종결 코돈이 없는 DsRed2 유전자를 위의 발현 시스템에 클로닝하여 적색형광실크를 제작하였다. 누에형질전환체 선발을 위해서는 3xP3 promoter와 EGFP 유전자를 이용하여 선발하였고, 1020개의 누에알에 microinjection 하여 F1 세대에서 6 broods의 형질전환체를 선발하였다. 선발된 누에형질전환체는 초기배 단계의 눈과 신경조직, 유충과 번데기 그리고 성충의 눈에서 EGFP 형광단백질이 발현되는 것을 확인 할 수 있었다. 또한 실크의 피브로인에서 DsRed2 단백질이 발현되는 것을 확인하기 위해, F2세대의 누에형질전환체 중에서 5령 5일 유충을 해부하여 견사선을 형광현미경으로 관찰하였고, 중부와 후부 견사선에서 적색형광단백질이 발현되는 것을 확인 할 수 있었고, F2 세대의 고치에서도 적색형광단백질의 발현을 확인할 수 있었다. 이상의 결과에서 적색형광실크를 생산하는 누에형질전환체가 성공적으로 제작되었음을 확인할 수 있었고 이러한 결과를 토대로 새로운 산업소재로서 실크를 활용할 수 있을 것으로 기대한다.

• 한국산학기술학회논문지
• /
• 제22권6호
• /
• pp.542-549
• /
• 2021

본 연구의 목적은 재조합 인간 상피세포 성장인자(hEGF)의 발현 확인 및 정제의 용이성을 위해 단백질의 N-말단에 융합된 부분을 제거하기위하여 기존의 고가의 효소를 사용하지 않고 간단한 화학처리로 융합 태그를 절단하면서도 여전히 친화성 크로마토그래피로 정제가 가능한 재조합 hEGF의 경제적이며 공정이 단순화된 제조법을 제공하는 것이다. 인간 상피세포 성장 인자는 인간 세포 성장 및 증식에 매우 중요한 호르몬이며 이 단백질에 대한 발현 및 정제에 관한 많은 연구가 보고 되었다. 본 연구에서는 hEGF 유전자를 대장균 코돈에 최적화 하였으며 N-말단에 Hydroxylamine에 의한 절단이 가능한 Asparagine과 Glycine이 발현되도록 포함하여 설계하였다. 제조한 DNA를 대장균 발현 벡터인 pRSET_A에 삽입하여 발현용 균주 BL21 (DE3)에 형질전환 시켰으며 재조합 융합 단백질은 대장균에서 샤페론 벡터 pG-Tf2와 성공적으로 공발현 되었다. 발현된 융합 단백질은 Ni-NTA 컬럼 크로마토그래피로 정제한 후 Hydroxylamine으로 처리해 N-말단 융합부분을 제거하였으며 SDS-PAGE를 통해 확인하였다. ELISA 분석 결과 재조합 EGF의 활성이 상업용 hEGF와 92% 이상 유사한 것으로 나타났으며 피부 섬유아세포의 세포증식을 촉진하는 것으로 확인 되었다.

• 한국발생생물학회:학술대회논문집
• /
• 한국발생생물학회 2003년도 제3회 국제심포지움 및 학술대회
• /
• pp.121-121
• /
• 2003

The standard protocol for the production of transgenic mouse from ES-injected embryo has to process via chimera producing and several times breeding steps, In contrast, tetraploid-ES cell complementation method allows the immediate generation of targeted murine mutants from genetically modified ES cell clones. The advantage of this advanced technique is a simple and efficient without chimeric intermediates. Recently, this method has been significantly improved through the discovery that ES cells derived from hybrid strains support the development of viable ES mice more efficiently than inbred ES cells do. Therefore, the objective of this study was to generate transgenic mice overexpressing human resistin gene by using tetrapioid-ES cell complementation method. Human resistin gene was amplified from human fetal liver cDNA library by PCR and cloned into pCR 2.1 TOPO T-vector and constructed in pCMV-Tag4C vector. Human resistin mammalian expression plasmid was transfected into D3-GL ES cells by lipofectamine 2000, and then after 8~10 days of transfection, the human resistin-expressing cells were selected with G418. In order to produce tetraploid embryos, blastomeres of diploid embryos at the two-cell stage were fused with two times of electric pulse using 60 V 30 $\mu$sec. (fusion rate : 93.5%) and cultured upto the blastocyst stage (development rate : 94.6%). The 15~20 previously G418-selected ES cells were injected into tetraploid blastocysts, and then transferred into the uterus of E2.5d pseudopregnant recipient mice. To investigate the gestation progress, two El9.5d fetus were recovered by Casarean section and one fetus was confirmed to contain human resistin gene by genomic DNA-PCR. Therefore, this finding demonstrates that tetraploid-ES mouse technology can be considered as a useful tool to produce transgenic mouse for the rapid analysis of gene function in vivo.

• BMB Reports
• /
• 제29권3호
• /
• pp.221-224
• /
• 1996

To examine the growth-phase dependent control of Escherichia coli rnpB gene we used a combination of Northern analysis for RNA determination and Southern analysis for plasmid DNA determination. The relative amounts of metabolically unstable transcript derived from the internally deleted rnpB gene harbored on a multicopy plasmid as well as the relative plasmid contents were measured by Northern analysis and Southern analysis, respectively, of total nucleic acids from E coli cells containing the plasmid. The relative transcription activity of the rnB was represented by a ratio of the relative amount of the transcript to that of the plasmid DNA during bacterial growth. The rnpB transcription increased rapidly with time during exponential growth, but started to decrease before the transition period of an exponential growing cell culture into the stationary phase. Although the expression pattern was similar to the changes of ${\beta}-galactosidase$ activity expressed from the lysogenic strain carrying the chromosomal rnpB-lacZ fusion which were shown in a previous work, the present data appears to represent a more actual growth-phase control of the rnpB transcription than the previous data by the ${\beta}-galactosidase$ assay. In addition the present method described for a direct analysis of both RNA and plasmid DNA provides a rapid and efficient method that can applied to an examination of transcription control by using a multicopy plasmid.

• Journal of Microbiology and Biotechnology
• /
• 제11권1호
• /
• pp.131-137
• /
• 2001

Previous work has identified that only the catabolite responsive element A (creA; previously called cre-2) out of two potential cre sequences (cre-1: nucleotide +160 to +173 and cre-2: +173 to +186), recognized within the coding region of the xylanaseA gene (xynA) of Bacillus stearothermophilus No.236, was actually, was actually involved in the carbon catabolite repression(CCR) of xynA expression in B. subtilis. However, the level of CCR of xynA expression in the original B.stearothermophilus No.236 strain (70-fold repression). Therefore, to search for an additional cre element in the promoter region, the upstream region of the xynA gene was subcloned by chromosome walking, and as a result, another potential cre element (nucleotide -124∼-137; designated creB) was recognized in this region. The cre-like sequence revealed a high homology to the cre consensus sequence. The xylanase activity of B. subtilis MW15 bearing pWPBR14 (containing creA and creB) cultured in a medium containing xylose as the sole carbon source was about 7.7 times higher than that observed for the same culture containing glucose. B. subtilis MW15 bearing pWPBR23 (containing only creA) produced an activity about 2.4 times higher. This pattern of CCR was confirmed using derivatives of xynA::aprA fusion plasmids. Furthermore, a measurement of the amounts of the xynA transcript showed a similar pattern as that for the production of xylanase. In addition, the synthesis of xylanase in B. subtilis QB7115 [a catabolite control protein A (ccpA) mutant strain] carrying pWPBR14 was almost completely relieved from glucose repression. Together, these results lead to a conclusion that the CCR of the expression of the xynA gene is mediated by CcpA binding at creA and creB sites in B. subtilis.

• 한국수정란이식학회지
• /
• 제17권2호
• /
• pp.101-108
• /
• 2002

Human Prourokinase (proUK) offers potential as a novel agent with improved fibrin specificity and, as such, may offer advantages as an attractive alternative to urokinase that is associated with clinical benefits in patients with acute peripheral arterial occlusion. For production of transgenic cow as human proUK bioreacotor, we conducted this study to establish efficient production system for bovine transgenic embryos by somatic cell nuclear transfer (NT) using human prourokinase gene transfected donor cell. An expression plasmid for human prourokinase was constructed by inserting a bovine beta-casein promoter, a green fluorescent protein (GFP) marker gene, and human prourokinase target gene into a pcDNA3 plasmid. Cumulus cells were used as donor cell and transfected with the expression plasmid using the Fugene 6 as a carrier. To increase the efficiency for the production of transgenic NT, development rates were compared between non-transfected and transfected cell in experiment 1, and in experiment 2, development rates were compared according to level of GFP expression in donor cells. In experiment 1, development rates of non-transgenic NT embryos were significantly higher than transgenic NT embryos (43.3 vs. 28.4％). In experiment 2, there were no significant differences in fusion rates (85.4 vs. 78.9％) and cleavage rates (78.7 vs. 84.4％) between low and high expressed cells. However, development rates to blastocyst were higher in low expressed cells (17.0 vs. 33.3％), and GFP expression rates in blastocyst were higher in high expressed cells (75.0 vs. 43.3％), significantly.